Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Global CRO Signs TrialOne Agreement With OmniComm Systems | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Global CRO Signs TrialOne Agreement With OmniComm Systems

New agreement expands commitment to TrialOne for early phase studies for the next seven years

By: Betsy Louda

, Contract Pharma

A global provider of drug development and commercialization solutions and services has signed a new agreement extending its relationship with OmniComm Systems, Inc. for another seven years. 

 
Under the terms of the agreement, the CRO will use OmniComm’s TrialOne eClinical solution to automate early phase studies at one of its U.S.-based clinical research units.

The global CRO selected TrialOne, apart from its status as the market-leading eSource and site automation system for Phase I clinics, because TrialOne enables research organizations to greatly improve the productivity and efficiency of their Phase I clinics.

TrialOne streamlines and automates key processes for early phase clinics, which drive efficiencies and reduce timelines and costs through faster and more directed volunteer recruitment, easy-to-build schedule-based workflows, real-time Bedside Data Collection (BDC), direct data capture from devices, sample processing automation and data processing. The automation reduces workload on clinic staff and improves the clinical trial experience for volunteers. The browser-based, tablet-compatible system provides an advanced platform for automating clinic operations, complies with FDA 21 CFR Part 11, and supports data standards such as CDISC for faster and easier exporting and reporting of data.

“Each new contract documents TrialOne’s position as the market-leading eSource solution for Phase I clinics,” said Kuno van der Post, Ph.D., OmniComm’s chief commercial officer. “We’re excited to continue building our partnership with this leading CRO.”
 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters